Who owns Galectin Therapeutics?
- Ticker: GALT
- CUSIP Number: 363225202
Tip: Access positions for across all investors
Analyze quarterly positions in Galectin Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Galectin Therapeutics stock
Who bought or sold Galectin Therapeutics this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 1.9M | $3.2M | 0% | Dec 2023 |
|
Advisor Group Holdings | 1.3M | $2.1M | -62% | Dec 2023 |
|
Geneos Wealth Management | 413k | $685k | -1% | Dec 2023 |
|
Atria Wealth Solutions | 250k | $415k | -4% | Dec 2023 |
|
Sontag Advisory | 184k | $305k | 0% | Dec 2023 |
|
Cambridge Investment Research Advisors | 127k | $210k | -8% | Dec 2023 |
|
Cutter & CO Brokerage | 118k | $195k | -9% | Dec 2023 |
|
683 Capital Management | 111k | $184k | 100% | Dec 2023 |
|
Commonwealth Equity Services | 105k | $175k | -1% | Dec 2023 |
|
Horizon Kinetics Asset Management | 54k | $89k | -4% | Dec 2023 |
|
D.A. Davidson & Co. | 43k | $71k | 13% | Dec 2023 |
|
Stratos Wealth Partners | 41k | $97k | 0% | Mar 2024 |
|
William Blair $ Company | 38k | $63k | 0% | Dec 2023 |
|
Independent Advisor Alliance | 36k | $60k | 0% | Dec 2023 |
|
Solutions 4 Wealth | 36k | $60k | 100% | Dec 2023 |
|
Traynor Capital Management | 35k | $83k | 0% | Mar 2024 |
|
Jane Street | 34k | $56k | 100% | Dec 2023 |
|
Retirement Guys Formula | 34k | $81k | 57% | Mar 2024 |
|
Millennium Management | 28k | $46k | -73% | Dec 2023 |
|
AE Wealth Management | 27k | $46k | 0% | Dec 2023 |
|
Creative Planning | 24k | $40k | 20% | Dec 2023 |
|
Beacon Capital Management | 24k | $46k | 90% | Dec 2023 |
|
Bank of New York Mellon | 23k | $38k | 0% | Dec 2023 |
|
Summit Trail Advisors | 20k | $48k | 0% | Mar 2024 |
|
Vivaldi Capital Management | 19k | $33k | 0% | Dec 2023 |
|
Wealth Enhancement Advisory Services | 19k | $45k | 0% | Mar 2024 |
|
Charles Schwab Investment Management | 17k | $29k | 0% | Dec 2023 |
|
Wedbush Morgan Securities | 16k | $26k | 0% | Dec 2023 |
|
Citadel Advisors | 15k | $24k | 100% | Dec 2023 |
|
Buckingham Asset Management | 13k | $22k | 0% | Dec 2023 |
|
Dynamic Advisors Solutions | 12k | $30k | 0% | Mar 2024 |
|
Inspire Advisors | 11k | $19k | 100% | Dec 2023 |
|
Mariner Wealth Advisors | 11k | $18k | 0% | Dec 2023 |
|
Citigroup | 11k | $18k | 100% | Dec 2023 |
|
Stock Yards Trust Company | 11k | $17k | 0% | Dec 2023 |
|
Wells Fargo & Company | 7.6k | $13k | -6% | Dec 2023 |
|
Ronald Blue Trust | 7.0k | $13k | 0% | Dec 2023 |
|
Simplex Trading | 7.0k | $11k | -35% | Dec 2023 |
|
Bank of America Corporation | 5.6k | $9.3k | 0% | Dec 2023 |
|
Barrett & Company | 3.8k | $9.2k | 0% | Mar 2024 |
|
Meeder Asset Management | 3.8k | $6.3k | 0% | Dec 2023 |
|
Gradient Investments | 3.8k | $6.3k | 0% | Dec 2023 |
|
Hartland & Co | 3.0k | $5.0k | 0% | Dec 2023 |
|
Sound Income Strategies | 3.0k | $7.1k | 0% | Mar 2024 |
|
IFP Advisors | 2.0k | $3.3k | 0% | Dec 2023 |
|
Jpmorgan Chase & Co | 1.8k | $3.0k | 1860% | Dec 2023 |
|
Benjamin F. Edwards & Company | 1.8k | $3.0k | -68% | Dec 2023 |
|
Royal Bank of Canada | 1.1k | $2.0k | 100% | Dec 2023 |
|
Bradley & Co. Private Wealth Management | 1.0k | $1.7k | 0% | Dec 2023 |
|
UBS Group | 622.00 | $1.0k | 100% | Dec 2023 |
|
Global Retirement Partners | 250.00 | $455.000000 | 0% | Dec 2023 |
|
Salem Investment Counselors | 167.00 | $399.998400 | 0% | Mar 2024 |
|
Who sold out of Galectin Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Pnc Financial Services | Sep 2023 | 56k | $108k |
Connor, Clark & Lunn Investment Management | Sep 2023 | 10k | $19k |
Farther Finance Advisors | Sep 2023 | 350.00 | $672.000000 |